The NYSCF Conference
To access the conference platform, please reference the e-mail sent to you from events@NYSCF.org (be sure to check spam/junk folders). If you experience any difficulties, please e-mail events@NYSCF.org or call 212-365-7452.
The NYSCF Conference is the leading scientific meeting on translational stem cell research. It annually convenes over 500 participants from academia, industry, government, non-profits, and patient groups. Speakers include world-renowned, multi-disciplinary scientists, who will present their latest findings about the transformative impact of stem cell research on numerous diseases with a high unmet need.
Sign up here to receive email updates and follow us on social media for the latest in conference news.
Confirmed Speakers, Panelists, and Chairs
- Domenico Accili, MD — Columbia University Medical Center
- Laura Andres-Martin, PhD — The NYSCF Research Institute
- Paola Arlotta, PhD – Harvard University
- Shuibing Chen, PhD – Weill Cornell Medicine
- Alice Chen-Plotkin, MD – University of Pennsylvania
- Jose Conejo-Garcia, MD, PhD – Moffitt Cancer Center
- Tobias Deuse, MD — University of California, San Francisco
- Jennifer Elisseeff, PhD – Johns Hopkins University
- Valentina Fossati, PhD – The NYSCF Research Institute
- Valentina Greco, PhD – Yale University
- Ya-Chieh Hsu, PhD – Harvard University
- Shane Liddelow, PhD – NYU Langone Health
- Alysson Muotri, PhD – University of California, San Diego
- Shahin Rafii, MD – Weill Cornell Medicine
- Carolyn Rodriguez, MD, PhD — Stanford University
- Lee Rubin, PhD – Harvard Stem Cell Institute
- Krishanu Saha, PhD – University of Wisconsin-Madison
- Sohrab Shah, PhD – Memorial Sloan Kettering Cancer Center
- Padmanee Sharma, MD, PhD — MD Anderson Cancer Center
- Jean Shin, PhD — National Institutes of Health
- Susan L. Solomon, JD – The NYSCF Research Institute
- Viviane Tabar, MD – Memorial Sloan Kettering Cancer Center
- Takanori Takebe, MD, PhD – Cincinnati Children’s Hospital Medical Center
- Craig B. Thompson, MD – Memorial Sloan Kettering Cancer Center
- Matthias von Herrath, MD – La Jolla Institute for Immunology; NovoNordisk
- Celia Witten, MD, PhD – Food and Drug Administration
- Rachel Yehuda, PhD – Icahn School of Medicine at Mount Sinai
|iPSC disease models||Organoids||Novel technologies|
|Regenerative medicine||Diversity and equity in STEM||Emerging therapies|
|Attendee category||Early until 09/15/2021||Regular from 09/16/2021|
|Commercial / Industry||$625||$675|
|*Healthcare Professional (non-academic)||$325||$375|
|*Non-Profit / Government / Academic||$275||$325|
|*Residents / Postdocs / Fellows||$150||$175|
*Proof of affiliation required.
Your conference registration includes access to the virtual conference platform, all sessions, and on-demand access of talks and conference content until December 31, 2021.
Full conference registration is required to attend any panels or sessions.
Registration links are unique to each user and cannot have multiple logins.
A confirmation e-mail is sent via e-mail at the time of registration. Should you need additional assistance, please e-mail firstname.lastname@example.org or call 212-365-7425.
Yes, you can transfer your registration up until 1 week prior to the conference. Registrations cannot be transferred after October 12, 2021.
Registrations are refundable, less a $75 administrative charge. All refunds must be received by written request to email@example.com by September 20, 2021. No-shows are not eligible for refund.
Yes, abstracts must be submitted by September 15, 2021 at 5:00 PM Eastern Time for consideration as a poster or short talk.
Poster presenters will upload a PDF of their poster into the conference platform. During the poster session, live video and text chats will be available to discuss your research.
Contact Ali Kean Hofer at firstname.lastname@example.org or 212-365-7425.